12.35
+0.494(+4.17%)
Currency In USD
Address
100 Columbia
Aliso Viejo, CA 92656
United States of America
Phone
949 521 7830
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
498
First IPO Date
July 30, 2021
| Name | Title | Pay | Year Born |
| Dr. Ronald M. Kurtz M.D. | Co-President, Chief Executive Officer & Director | 1.44M | 1963 |
| Ms. Shelley B. Thunen | Co-President & Chief Financial Officer | 877,380 | 1954 |
| Mr. Eric J. Weinberg | Co-President & Chief Commercial Officer | 877,380 | 1961 |
| Dr. Ilya Goldshleger Ph.D. | Co-President & Chief Operating Officer | 899,880 | 1975 |
| Mr. Patrick Cullen | Executive Vice President of Quality & Infrastructure Operations | 0 | N/A |
| Mr. Scott Gaines | Executive Vice President of Manufacturing & Commercial Operations | 0 | N/A |
| Ms. Maureen O'Connell | Executive Vice President of Clinical & Regulatory Affairs | 0 | N/A |
| Mr. Oliver Moravcevic | Vice President of Investor Relations | 0 | N/A |
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.